Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2Y04

TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND PARTIAL AGONIST SALBUTAMOL

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsESRF BEAMLINE ID23-2
Synchrotron siteESRF
BeamlineID23-2
Temperature [K]100
Detector technologyCCD
Collection date2009-06-26
DetectorMARRESEARCH
Spacegroup nameP 1 21 1
Unit cell lengths89.900, 62.000, 101.500
Unit cell angles90.00, 109.90, 90.00
Refinement procedure
Resolution95.400 - 3.050
R-factor0.22484
Rwork0.223
R-free0.25518
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)2vt4
RMSD bond length0.012
RMSD bond angle1.438
Data reduction softwareMOSFLM
Data scaling softwareSCALA
Phasing softwarePHASER
Refinement softwareREFMAC (5.5.0109)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]38.6003.210
High resolution limit [Å]3.0503.050
Rmerge0.1200.510
Number of reflections19354
<I/σ(I)>7.71.8
Completeness [%]95.589.5
Redundancy2.92.4
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP9277SITTING DROP VAPOUR DIFFUSION, PROTEIN (16.5MG/ML) IN 100MM NACL, 0.1MM EDTA, 1.0MM (R, S)-SALBUTAMOL, 1.0MG/ML CHS, 0.5% HEGA-10, 0.1M BICINE PH9.0, 28% PEG400 AT 4 DEGREES C

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon